Hypha Labs, Inc. (FUNI)
Stock analysis · OTC · Healthcare · Medical - Diagnostics & Research
$0.00
Market Cap
$557.25K
PE (TTM)
-0.27
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
1.35
Day Range
$0.00 – $0.00
52-wk Range
$0.00 – $0.04
Avg Volume
N/A
Volume
50.00K
Hypha Labs, Inc. (FUNI) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $557.25K. Trailing PE -0.27. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Proprietary Signals
About Hypha Labs, Inc.
Hypha Labs, Inc. focuses on the investigation, development, and market release of bioreactor systems across the United States. Their key offering is the Hypha Micropearl bioreactor, a specialized household device engineered to rapidly cultivate beneficial mushrooms for dietary intake. Founded in 2010, the company is officially based in Las Vegas, Nevada.
Valuation
| P/E (TTM) | -0.27× |
|---|---|
| P/S (TTM) | 0.00× |
| P/B | -0.18× |
| P/FCF (TTM) | -0.93× |
| EV / EBITDA | -1.60× |
| EV / Sales | 0.00× |
| Earnings Yield | -342.03% |
| Free Cash Flow Yield | -107.55% |
Fundamentals
| Enterprise Value | $2.35M |
|---|---|
| Net Income (TTM) | -$1.91M |
| Free Cash Flow (TTM) | -$262.33K |
| Net Debt | $1.79M |
| Working Capital | -$1.58M |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | 73.84% |
| Return on Invested Capital | 114.69% |
Peers
Recent News
Related
Browse more tickers: sitemap